Effectiveness of an Intervention in Improving Medication Adherence Among Malay Patients With Underlying Type 2 Diabetes Mellitus in Malaysia
NCT03228706
Behavior, Diabetes Mellitus
Kota Samarahan, Sarawak, Malaysia
View Trial DetailsNCT Number: NCT02730754
This study aims to determine which factors are related to change in diabetes-related distress and change in depressive symptoms after three years of follow-up in Asian adults with type 2 diabetes mellitus in primary care. The investigators will explore the impact of patient demographics, cardiometabolic control, medications adherence, health-related quality of life, self-efficacy and self-management behaviors on diabetes-related distress and depressive symptoms.
Looking for future studies?
Notify Me30 year and older
All sexes
Observational
Patients with type 2 diabetes mellitus (T2DM) have been shown to experience psychological burden and distorted illness perception. These psychological burden include feeling of burned-out, fatigue, distress and depression, and in addition of distorted illness perception often lead to difficulty in coping with the demands of life-style changes and adherence to medication. Diabetes-related distress (DRD) and depressive symptoms (DS) were associated with glycaemic control and medication adherence, and life-styles behaviors, respectively. However, evidence on the relationships between DRD, DS and clinically significant outcomes are scarce in Asian adults with T2DM. Primary care patients who participated before will be re-invited. This is a repeated cross-sectional study of a cohorts of 700 patients who were first studied in 2013 (Emotional Distress in adults with type 2 Diabetes Mellitus & Quality of Life [EDDMQoL] study with the National Medical Research Register (NMRR) identification number: NMRR-12-1167-14158). Demographic data (age, gender, ethnicity, religion, educational level, occupation and monthly income), smoking status, self-perceive social support and health literacy will be collected by questionnaires.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline and 3 year
Change in diabetes-related distress
Time frame: Baseline and 3 year
Change in depressive symptoms
Time frame: Baseline and 3 year
Change in both diabetes-related distress and depressive symptoms combined
Time frame: Through study completion
Cross-sectional, an association with other variables
Time frame: Through study completion
Cross-sectional, an association with other variables
Time frame: Baseline and 3-year
Standard deviations of the HbA1c from the medical records
Time frame: Baseline and 3-year
Standard deviations of the systolic blood pressures from the medical records
Time frame: Baseline and 3-year
Standard deviations of the pulse rates from the medical records
Time frame: 3-year
Retrospective records of the number of visits to healthcare facilities and hospitalisation from the medical records
Universiti Putra Malaysia
Other
Relationship Between Emotional Disorders (Diabetes Distress and Depression) and Outcomes (Self-care and Clinical) in Adults With Type 2 Diabetes Mellitus in Primary Care: A Retrospective Cohort Study
Acronym: EDDMQoL-Pro
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03228706
Behavior, Diabetes Mellitus
Kota Samarahan, Sarawak, Malaysia
View Trial DetailsNCT03502109
Behavior, Cardiovascular Diseases
Santiago, Chile
View Trial DetailsNCT02730078
Diabetes Mellitus, Diabetes Mellitus, Type 2
View Trial DetailsNCT02955238
Arterial Occlusive Diseases, Arteriosclerosis
Chula Vista, California, United States
View Trial Details